Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 5.68
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers.
Data is available to registered users only
Target Price
The average target price of OM is 11 and suggests 93% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase o
Data is available to registered users only
Buy
Sell